跳至主要内容
临床试验/CTRI/2024/04/065998
CTRI/2024/04/065998尚未招募2 期

Clinical evaluation of Rohitakadi Vati in Prameha with special reference to type-2 Diabetes Mellitus – a Randomized placebo-controlled trial. - Nill

Dr Mohit Pandit0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Confirmed diagnosis of type-2 diabetes mellitus according to American Diabetes Association criteria.
  • 2) Fasting glucose level between 125 to 200 mg/dL, Post prandial blood sugar level 200 to 280 mg/dL.
  • 3) HbA1c level between 6.4 to 7.5 %.

排除标准

  • 1) Type-1 diabetes mellitus
  • 2) Gestational diabetes
  • 3) Patient with type 2 diabetes mellitus below age 30 years and above age 60 years.
  • 4) Patients with fasting sugar more than 200 mg/dL and post prandial more than 280 mg/dL will be excluded from study.
  • 5) Pregnancy or breastfeeding.
  • 6) History of severe diabetic complications, such as diabetic ketoacidosis.
  • 7) Patients with history of severe liver, kidney or heart disease.
  • 8) Patients having any other life threatening disease.

研究者

发起方
Dr Mohit Pandit

相似试验